Investment Rating - The investment rating for the company is "Buy" and is maintained [10]. Core Views - The company achieved revenue, net profit attributable to the parent, and net profit excluding non-recurring items of 842 million, 85 million, and 69 million yuan respectively in H1 2025, representing year-on-year growth of 20%, 18%, and 26% [2][6]. - In Q2 2025, the figures were 411 million, 42 million, and 34 million yuan, with year-on-year growth of 20%, 20%, and 24% [2][6]. - The company is expected to continue benefiting from product structure optimization and the rise of e-commerce, with strong sales performance anticipated for the new recombinant protein toothpaste in H2 [2][12]. Revenue Summary - Revenue from e-commerce channels grew significantly, while offline channels remained stable. In H1 2025, e-commerce and other revenues increased by 81% year-on-year, while offline revenue decreased by 1%, accounting for 39% and 61% of total revenue respectively [11]. - The adult toothpaste segment saw a 23% increase in revenue, while the adult toothbrush segment grew by 4%. Revenue from oral medical and beauty care products increased by 55% [11]. Profitability Summary - The company experienced improvements in product structure and increased investment in e-commerce, leading to a rise in gross sales and stable net profit margins. In Q2 2025, the gross profit margin improved by 4.2 percentage points year-on-year [11]. - The online and offline gross profit margins increased by 11.3 and 1.5 percentage points respectively in H1 2025 [11]. Product Development and Market Strategy - The company is focusing on the launch of new products, with the recombinant protein toothpaste expected to be promoted heavily in the second half of the year. The product is designed to aid in the repair of damaged teeth and gums [12]. - The company is leveraging the growth of e-commerce platforms, particularly Douyin, to enhance brand visibility and market share, with a significant portion of sales now coming from online channels [8][12]. Financial Forecast - The company is projected to achieve net profits attributable to the parent of 200 million, 260 million, and 330 million yuan for the years 2025, 2026, and 2027 respectively, with corresponding price-to-earnings ratios of 34, 27, and 21 times [12].